Literature DB >> 33727940

The Effects of Traditional Chinese Medicine-Associated Complementary and Alternative Medicine on Women with Polycystic Ovary Syndrome.

Wenjuan Shen1, Bao Jin2, Yujia Pan2, Yanhua Han1, Tianjiao You2, Zongyu Zhang2, Yangfan Qu2, Sha Liu3, Yang Zhang4.   

Abstract

Polycystic ovary syndrome (PCOS) is a touchy clinical and public health problem worldwide, which adversely affects women's health and health-related comorbidities for lifetime, and represents a tremendous burden for both the family of the patient and for society. According to the diagnostic criteria used and the population studied, the prevalence rate of PCOS is between 6% and 21%. However, current conventional modern medicines for PCOS are only moderately effective at controlling the signs and symptoms, while they are not thoroughly able to prevent complications. Therefore, many patients have turned to complementary and alternative medical (CAM) treatments. CAM use is wide spread among patients with PCOS, and more than 70% of patients use CAM at one point during their diseases. The patients' primary motivations include dissatisfaction with available medications, perceive higher risk of drug side effects and crushing health burden and economic costs, desire for symptom relief, pursuit of shortening the course of disease, and the belief that CAM therapy is in accordance with the patients' values and beliefs. At present, several CAM methods have been used in women with PCOS, which has achieved obvious effects. However, biologically plausible mechanisms of the action of traditional Chinese medicine- (TCM-) associated CAM for PCOS have not been systematically reviewed. This review briefly summarizes the current progress of the impact of herbal medicine on the outcomes of PCOS and introduces the mechanisms.
Copyright © 2021 Wenjuan Shen et al.

Entities:  

Year:  2021        PMID: 33727940      PMCID: PMC7935578          DOI: 10.1155/2021/6619597

Source DB:  PubMed          Journal:  Evid Based Complement Alternat Med        ISSN: 1741-427X            Impact factor:   2.629


  68 in total

1.  Efficacy of Salvia officinalis extract on the prevention of insulin resistance in euglycemic patients with polycystic ovary syndrome: A double-blinded placebo-controlled clinical trial.

Authors:  Leila Amini; Faraz Mojab; Shayesteh Jahanfar; Mahdi Sepidarkish; Zahra Raoofi; Arezoo Maleki-Hajiagha
Journal:  Complement Ther Med       Date:  2019-11-13       Impact factor: 2.446

2.  The Impact of Green Tea Supplementation on Anthropometric Indices and Inflammatory Cytokines in Women with Polycystic Ovary Syndrome.

Authors:  Esmat Mombaini; Sima Jafarirad; Durdana Husain; Mohammad Hossein Haghighizadeh; Parivash Padfar
Journal:  Phytother Res       Date:  2017-02-28       Impact factor: 5.878

3.  The effects of curcumin supplementation on oxidative stress, Sirtuin-1 and peroxisome proliferator activated receptor γ coactivator 1α gene expression in polycystic ovarian syndrome (PCOS) patients: A randomized placebo-controlled clinical trial.

Authors:  Javad Heshmati; Fereshteh Golab; Mojgan Morvaridzadeh; Eric Potter; Maryam Akbari-Fakhrabadi; Farnaz Farsi; Sara Tanbakooei; Farzad Shidfar
Journal:  Diabetes Metab Syndr       Date:  2020-01-08

4.  [Combined therapy of Chinese medicine with in vitro fertilization and embryo transplantation for treatment of polycystic ovarian syndrome].

Authors:  Fang Lian; Zhen-Gao Sun; Jian-Wei Zhang
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2008-11

5.  The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment.

Authors:  Yuan An; Zhuangzhuang Sun; Yajuan Zhang; Bin Liu; Yuanyuan Guan; Meisong Lu
Journal:  Clin Endocrinol (Oxf)       Date:  2013-08-09       Impact factor: 3.478

6.  Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome.

Authors:  Xiao-Ke Wu; Yong-Yan Wang; Jian-Ping Liu; Rui-Ning Liang; Hui-Ying Xue; Hong-Xia Ma; Xiao-Guang Shao; Ernest H Y Ng
Journal:  Fertil Steril       Date:  2016-06-20       Impact factor: 7.329

7.  Effects of curcumin on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.

Authors:  Mehri Jamilian; Fatemeh Foroozanfard; Elham Kavossian; Esmat Aghadavod; Rana Shafabakhsh; Asma Hoseini; Zatollah Asemi
Journal:  Clin Nutr ESPEN       Date:  2020-01-30

8.  Kuntai capsules improve glucolipid metabolism in patients with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.

Authors:  Ruining Liang; Zhen Liu; Peishuang Li; Pei Fan; Ling Xu; Xueyan Sun; Jiahua Peng; Xuemei Peng; Meinan Zhang
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

9.  Phytoestrogen exposure is associated with circulating sex hormone levels in postmenopausal women and interact with ESR1 and NR1I2 gene variants.

Authors:  Yen-Ling Low; Alison M Dunning; Mitch Dowsett; Elizabeth Folkerd; Deborah Doody; James Taylor; Amit Bhaniani; Robert Luben; Kay-Tee Khaw; Nick J Wareham; Sheila A Bingham
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-05       Impact factor: 4.254

10.  Identification of the Active Constituents and Significant Pathways of Cangfu Daotan Decoction for the Treatment of PCOS Based on Network Pharmacology.

Authors:  Wenting Xu; Mengyu Tang; Jiahui Wang; Lihong Wang
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-21       Impact factor: 2.629

View more
  4 in total

1.  Identification of Bioactive Compounds and Potential Mechanisms of Kuntai Capsule in the Treatment of Polycystic Ovary Syndrome by Integrating Network Pharmacology and Bioinformatics.

Authors:  Xiushen Li; Jingxin Ma; Li Guo; Chenle Dong; Guli Zhu; Wenli Hong; Can Chen; Hao Wang; Xueqing Wu
Journal:  Oxid Med Cell Longev       Date:  2022-04-28       Impact factor: 7.310

2.  Obesity management in polycystic ovary syndrome: disparity in knowledge between obstetrician-gynecologists and reproductive endocrinologists in China.

Authors:  Ruilin Ma; Ying Zou; Wei Wang; Qingmei Zheng; Ying Feng; Han Dong; Zhangyun Tan; Xiaoqin Zeng; Yinqing Zhao; Yan Deng; Yanfang Wang; Aijun Sun
Journal:  BMC Endocr Disord       Date:  2021-09-06       Impact factor: 2.763

Review 3.  Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing.

Authors:  Hosna Mohammad Sadeghi; Ida Adeli; Daniela Calina; Anca Oana Docea; Taraneh Mousavi; Marzieh Daniali; Shekoufeh Nikfar; Aristidis Tsatsakis; Mohammad Abdollahi
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

Review 4.  Polycystic Ovarian Syndrome: A Complex Disease with a Genetics Approach.

Authors:  Himani Nautiyal; Syed Sarim Imam; Sultan Alshehri; Mohammed M Ghoneim; Muhammad Afzal; Sami I Alzarea; Emine Güven; Fahad A Al-Abbasi; Imran Kazmi
Journal:  Biomedicines       Date:  2022-02-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.